THP-1/MV-4-11 against-1, identified by the CAS number 2978623-53-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds in this category typically exhibit properties that make them suitable for biological activity, including selectivity towards certain biological targets and favorable pharmacokinetic profiles. The compound may be evaluated for its efficacy in inhibiting specific pathways or interactions relevant to disease mechanisms, particularly in oncology or infectious disease contexts. Additionally, its safety profile, including toxicity and side effects, would be assessed through preclinical and clinical studies. As with many novel compounds, ongoing research is essential to fully elucidate its mechanism of action, optimal dosing regimens, and potential for clinical use. For precise details regarding its chemical structure and specific applications, consulting specialized databases or scientific literature is recommended.

THP-1/MV-4-11 against-1

2978623-53-7: THP-1/MV-4-11 against-1, identified by the CAS number 2978623-53-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds in this category typically exhibit properties that make them suitable for biological activity, including selectivity towards certain biological targets and favorable pharmacokinetic profiles. The compound may be evaluated for its efficacy in inhibiting specific pathways or interactions relevant to disease mechanisms, particularly in oncology or infectious disease contexts. Additionally, its safety profile, including toxicity and side effects, would be assessed through preclinical and clinical studies. As with many novel compounds, ongoing research is essential to fully elucidate its mechanism of action, optimal dosing regimens, and potential for clinical use. For precise details regarding its chemical structure and specific applications, consulting specialized databases or scientific literature is recommended.

<p>Compound 12k (THP-1/MV-4-11 against-1) is a 5-substituted thiazolyl urea anticancer agent with significant inhibitory efficacy against THP-1/MV-4-11 cancer cells, demonstrating IC50 values of 29 nM and 98 nM, respectively.</p>

CAS 2978623-53-7

THP-1/MV-4-11 against-1

THP-1/MV-4-11 against-1

Ref: TM-T203588